Averin Capital Acquisition Corp.
ACAA
NASDAQ Global Market10.00
USD
- -
- -
CIK
0002096900
ISIN
KYG0679A1004
CUSIP
G0679A100
Return %
Stock
S&P500
1Y
-0.50
18.21
3Y
-0.50
63.29
5Y
-0.50
74.90
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- David A. Berry
- Full Time Employees
- 3
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 240 West 40th Street New York NY United States of America 10018
- IPO Date
- Apr 10, 2026
- CIK
- 0002096900
- Website
- averincapital.com
- Similar Companies
- Business
- Averin Capital Acquisition Corp. is a blank-check company organized to effect a merger, amalgamation, share exchange, asset acquisition, or other similar business combination with one or more businesses, with a focus on opportunities at the intersection of technology and healthcare, and is led by an experienced management team aiming to generate attractive returns for shareholders. The company plans to pursue targets primarily within technology and healthcare sectors, leveraging a trust-funded financing structure to facilitate a future business combination; it intends to concentrate its search on opportunities in these industries and to deploy capital through a combination of cash in trust and equity considerations to maximize value upon closing. Headquartered in New York, Averin Capital Acquisition Corp. is founded in 2025 and operates as a Nasdaq-listed SPAC vehicle, with a management team including David A. Berry as Chairman and Chief Executive Officer and Alex Lau as Chief Financial Officer and Secretary, among others. Its primary products and services consist of identifying, evaluating, and consummating one or more business combinations with qualifying targets, providing strategic oversight and post-transaction management to integrate acquired entities and pursue growth opportunities. Latest major changes include the completion of its initial public offering raising $250 million in gross proceeds via 25,000,000 units at $10.00 per unit, with each unit comprising one Class A ordinary share and one-sixth of a redeemable warrant, listing on Nasdaq under the ticker ACAAU and subsequent closing of the offering; and the company establishing a stated focus on tech and health sector targets and preparing for a future merger or acquisition with operating companies, as publicly disclosed in February 2026. These developments reflect a strategic shift toward rapid deployment of capital into technology and healthcare businesses, with a strengthened balance sheet and a defined path to a business combination through a trust-based structure and a reverse merger framework. The industry and business segments span blank-check vehicles and special purpose acquisition companies (SPACs), with target markets including technology and healthcare enterprises seeking strategic capital, scale opportunities, and operational expertise; the geographic footprint centers on the United States, with headquarters in New York and listings on Nasdaq Global Market, and potential collaborations or affiliations with financial sponsors and underwriters supporting the IPO and future transactions. Subsidiaries or parent relationships are not detailed at length, given the SPAC structure, though the company operates as a standalone entity seeking to merge with or acquire operating targets under its own corporate umbrella.